Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 24% ± 8% | |
retinal cone cell | 3 studies | 22% ± 5% | |
endothelial cell of vascular tree | 3 studies | 21% ± 5% |
Insufficient scRNA-seq data for expression of ZNF366 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 356.33 | 649 / 653 | 62% | 1.46 | 373 / 605 |
kidney | 99% | 184.53 | 88 / 89 | 56% | 3.12 | 508 / 901 |
breast | 100% | 610.61 | 459 / 459 | 54% | 1.17 | 608 / 1118 |
brain | 72% | 114.37 | 1913 / 2642 | 64% | 1.31 | 451 / 705 |
esophagus | 90% | 185.20 | 1297 / 1445 | 44% | 0.89 | 81 / 183 |
lung | 99% | 379.33 | 572 / 578 | 35% | 0.66 | 401 / 1155 |
stomach | 84% | 114.16 | 302 / 359 | 43% | 0.94 | 124 / 286 |
prostate | 93% | 186.90 | 229 / 245 | 29% | 0.48 | 144 / 502 |
intestine | 95% | 179.13 | 922 / 966 | 23% | 0.45 | 122 / 527 |
adrenal gland | 88% | 99.43 | 226 / 258 | 26% | 0.50 | 59 / 230 |
bladder | 100% | 213.48 | 21 / 21 | 10% | 0.17 | 50 / 504 |
uterus | 100% | 445.81 | 170 / 170 | 8% | 0.11 | 35 / 459 |
adipose | 100% | 734.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 275.65 | 241 / 241 | 0% | 0 | 0 / 0 |
pancreas | 56% | 49.05 | 185 / 328 | 42% | 0.87 | 75 / 178 |
heart | 98% | 308.33 | 840 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 168.05 | 770 / 803 | 0% | 0 | 0 / 0 |
skin | 58% | 75.64 | 1054 / 1809 | 23% | 0.46 | 107 / 472 |
ovary | 68% | 91.99 | 123 / 180 | 4% | 0.05 | 16 / 430 |
blood vessel | 72% | 132.83 | 960 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 0.96 | 12 / 29 |
tonsil | 0% | 0 | 0 / 0 | 38% | 0.88 | 17 / 45 |
liver | 18% | 15.38 | 41 / 226 | 9% | 0.15 | 38 / 406 |
peripheral blood | 24% | 25.65 | 222 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043627 | Biological process | response to estrogen |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0033147 | Biological process | negative regulation of intracellular estrogen receptor signaling pathway |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
Gene name | ZNF366 |
Protein name | Zinc finger protein 366 Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT) |
Synonyms | |
Description | FUNCTION: Has transcriptional repression activity. Acts as a corepressor of ESR1; the function seems to involve CTBP1 and histone deacetylases. . |
Accessions | Q8N895 ENST00000318442.6 Q0VAH5 F8W732 ENST00000414109.2 |